This topic contains a solution. Click here to go to the answer

Author Question: Which assay would assess for the presence of a circulating nonspecific inhibitor? a. Bethesda ... (Read 25 times)

xroflmao

  • Hero Member
  • *****
  • Posts: 515
Which assay would assess for the presence of a circulating nonspecific inhibitor?
 
  a. Bethesda titer
  b. Factor-specific inhibitor
  c. Lupus anticoagulant
  d. D-dimer

Question 2

Which of the following is needed to perform an activated partial thromboplastin time?
 
  a. Potassium chloride and partial thromboplastin reagent
  b. Partial thromboplastin reagent and calcium chloride
  c. Thromboplastin and potassium chloride
  d. Thromboplastin and calcium chloride



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macagn

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

Correct Answer: C

Answer to Question 2

Correct Answer: B




xroflmao

  • Member
  • Posts: 515
Reply 2 on: Jun 25, 2018
Excellent


kjohnson

  • Member
  • Posts: 330
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

For a complete list of videos, visit our video library